Aflac Incorporated (NYSE:AFL) is Lawson Kroeker Investment Management Inc. NE’s 10th Largest Position

Lawson Kroeker Investment Management Inc. NE lowered its position in Aflac Incorporated (NYSE:AFL) by 16.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 129,545 shares of the financial services provider’s stock after selling 25,786 shares during the period. Aflac comprises approximately 2.5% of Lawson Kroeker Investment Management Inc. NE’s holdings, making the stock its 10th largest position. Lawson Kroeker Investment Management Inc. NE’s holdings in Aflac were worth $13,400,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the business. Darwin Wealth Management LLC purchased a new position in Aflac in the 3rd quarter valued at approximately $34,000. Raelipskie Partnership purchased a new position in shares of Aflac in the third quarter valued at $38,000. Covestor Ltd raised its stake in shares of Aflac by 41.8% during the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after buying an additional 107 shares during the last quarter. Kennebec Savings Bank purchased a new stake in shares of Aflac in the 3rd quarter worth about $45,000. Finally, Catalyst Capital Advisors LLC acquired a new stake in Aflac in the 3rd quarter valued at about $51,000. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Aflac

In other news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the transaction, the executive vice president now directly owns 222,618 shares in the company, valued at approximately $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.90% of the stock is owned by insiders.

Aflac Stock Performance

Shares of NYSE:AFL opened at $107.76 on Thursday. The business has a 50-day moving average of $105.73 and a two-hundred day moving average of $106.25. The firm has a market capitalization of $59.87 billion, a PE ratio of 16.23, a P/E/G ratio of 2.10 and a beta of 1.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.69 by $0.47. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The firm had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. During the same quarter last year, the firm posted $1.84 earnings per share. Aflac’s revenue for the quarter was down 40.4% compared to the same quarter last year. As a group, research analysts forecast that Aflac Incorporated will post 7.26 earnings per share for the current year.

Aflac Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be given a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a yield of 2.15%. This is a boost from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Wednesday, February 19th. Aflac’s dividend payout ratio is 34.94%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Truist Financial lifted their target price on shares of Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Barclays upped their target price on Aflac from $96.00 to $98.00 and gave the company an “underweight” rating in a research note on Monday, January 6th. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research report on Wednesday, January 8th. Bank of America upped their price objective on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. Finally, Evercore ISI decreased their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research note on Wednesday, December 4th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the company. According to MarketBeat, Aflac currently has an average rating of “Hold” and a consensus price target of $102.67.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.